Biodesix Other Stockholder Equity from 2010 to 2024

BDSX Stock  USD 1.61  0.01  0.63%   
Biodesix Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity will likely drop to about 264.7 M in 2024. During the period from 2010 to 2024, Biodesix Other Stockholder Equity regression line of annual values had r-squared of  0.64 and arithmetic mean of  117,978,832. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
424.1 M
Current Value
264.7 M
Quarterly Volatility
166 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.5 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or PTB Ratio of 34.64. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Biodesix over the last few years. It is Biodesix's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Biodesix Other Stockholder Equity Regression Statistics

Arithmetic Mean117,978,832
Geometric Mean24,947,052
Coefficient Of Variation140.66
Mean Deviation147,785,243
Median7,675,000
Standard Deviation165,952,239
Sample Variance27540.1T
Range421.7M
R-Value0.80
Mean Square Error10638.5T
R-Squared0.64
Significance0.0003
Slope29,716,580
Total Sum of Squares385562T

Biodesix Other Stockholder Equity History

2024264.7 M
2023424.1 M
2022387.9 M
2021321.7 M
2020300 M
20192.3 M

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity424.1 M264.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.